Searchable abstracts of presentations at key conferences in endocrinology

ea0086p156 | Adrenal and Cardiovascular | SFEBES2022

Whole genome sequencing and Sanger sequencing to identify novel mutations in adrenal tumours from cats with primary hyperaldosteronism

Watson Alice , Syme Harriet , Brown Morris

Primary Hyperaldosteronism (PA) is caused by adrenal tumours or bilateral adrenal hyperplasia (Djajadiningrat-Laanen et al., 2011) causing constitutive aldosterone production. Both germline and somatic mutations have been identified in human PA (Scholl, 2022). The commonest somatic mutations in benign tumours causing PA in humans include KCNJ5, CACNA1D, ATP1A1 and ATP2B3 (Williams et al., 2015). It is hypothesized that analogous somatic mutations arise in fel...

ea0025p346 | Thyroid | SFEBES2011

Changes in urinary fractional excretion (FE) of calcium and phosphate following treatment of hyperthyroid cats

Williams Tim , Elliott Jonathan , Syme Harriet

Hyperthyroid cats have elevated parathyroid hormone (PTH) concentrations and suppressed fibroblast growth factor-23 (FGF-23) concentrations, both of which normalise following treatment of hyperthyroidism. PTH, FGF-23, and thyroid hormone can influence the renal reabsorption of calcium and phosphate. The aim of the present study was to assess the influence of hyperthyroidism on renal tubular function in cats indirectly, by comparing the FE of electrolytes in hyperthyroid cats w...

ea0013p315 | Thyroid | SFEBES2007

Subclinical hyperthyroidism in cats

Wakeling Jennifer , Elliott Jonathan , Syme Harriet

Cats are the only species, other than humans, in which naturally occurring, non-malignant hyperthyroidism has been recorded. Feline hyperthyroidism has many similarities to toxic nodular goitre, including age at risk, presentation, histological features and similar ‘switch-on’ mutations of the TSH receptor and linked G-proteins. Subclinical hyperthyroidism is well recognised in humans but has only recently been described in cats. We present preliminary data from a pr...

ea0031p329 | Steroids | SFEBES2013

P450 side-chain cleavage enzyme autoantibodies in canine Addison's disease

Boag Alisdair , McLaughlin Kerry , Christie Mike , Graham Peter , Syme Harriet , Catchpole Brian

Background: Addison’s disease (AD) in both humans and dogs is characterised by corticosteroid deficiency requiring lifelong hormone therapy. In humans autoimmune pathogenesis is established; at diagnosis ~90% of patients are 21-hydroxylase (21-OH) autoantibody positive, with antibodies to other adrenal antigens also detected. The pathogenesis of canine AD is less well characterised; autoimmune mechanisms are suspected, with anti-adrenal autoantibodies demonstrated by indi...

ea0094oc7.3 | Thyroid | SFEBES2023

Influence of tyrosine availability on TSH-dependent cell proliferation and gene transcription in rat FRTL-5 thyroid cells

Crossley Victoria , Simbi Bigboy , Chang Ruby , Elliott Jonathan , Fowkes Robert , Syme Harriet

Tyrosine availability critically influences thyroid hormone synthesis, and thyroid disorders, such as hyperthyroidism, affect 1% of humans. In contrast, nearly 10% of mature/senior cats develop hyperthyroidism, but colourpoint breeds with mutations in the tyrosinase gene (e.g. Siamese) show reduced risk of developing hyperthyroidism, potentially due to increased availability of tyrosine (related to coat colouration). To establish how tyrosine availability can alter thyroid fun...